Property in the body feminist perspectives

We live in an era when all bodies are potentially 'feminised' by being rendered 'open-access' for biomedical research and clinical practice. Adopting a theoretically sophisticated and practical approach, Property in the Body: Feminist Perspectives rejects the notion that the sale...

Full description

Main Author: Dickenson, Donna
Format: eBook
Language:English
Published: Cambridge Cambridge University Press 2017
Edition:Second edition
Series:Cambridge bioethics and law
Subjects:
Online Access:
Collection: Cambridge Books Online - Collection details see MPG.ReNa
LEADER 01892nmm a2200289 u 4500
001 EB001491673
003 EBX01000000000000000921262
005 00000000000000.0
007 cr|||||||||||||||||||||
008 170620 ||| eng
020 |a 9781316675984 
050 4 |a TP248.23 
100 1 |a Dickenson, Donna 
245 0 0 |a Property in the body  |b feminist perspectives  |c Donna Dickenson 
250 |a Second edition 
260 |a Cambridge  |b Cambridge University Press  |c 2017 
300 |a xxi, 202 pages  |b digital 
653 |a Biotechnology / Moral and ethical aspects 
653 |a Human body 
653 |a Feminist theory 
041 0 7 |a eng  |2 ISO 639-2 
989 |b CBO  |a Cambridge Books Online 
490 0 |a Cambridge bioethics and law 
856 |u https://doi.org/10.1017/9781316675984  |x Verlag  |3 Volltext 
082 0 |a 174.957 
520 |a We live in an era when all bodies are potentially 'feminised' by being rendered 'open-access' for biomedical research and clinical practice. Adopting a theoretically sophisticated and practical approach, Property in the Body: Feminist Perspectives rejects the notion that the sale of bodily tissue enhances the freedom of the individual through an increase in moral agency. Combining feminist theory and bioethics, it also addresses the omissions which are inherent in policy analysis and academic debate. For example, whilst women's tissue is particularly central to new biotechnologies, the requirement for female labour is largely ignored in subsequent evaluation. In its fully revised second edition, this book also considers how policies and developments vary between countries and within specific areas of biomedicine itself. Most importantly, it analyses the new and emerging technologies of this field whilst returning to the core questions and fears which are inextricably linked to the commercialisation of the body